3,4-dihydroxyphenylacetic acid and quinuclidines

3,4-dihydroxyphenylacetic acid has been researched along with quinuclidines in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bencherif, M; Kucinski, A; Stachowiak, EK; Stachowiak, MK; Syposs, C; Wersinger, S1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetic acid and quinuclidines

ArticleYear
α7 neuronal nicotinic receptor agonist (TC-7020) reverses increased striatal dopamine release during acoustic PPI testing in a transgenic mouse model of schizophrenia.
    Schizophrenia research, 2012, Volume: 136, Issue:1-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Acoustic Stimulation; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microdialysis; Neural Inhibition; Nicotinic Agonists; Quinuclidines; Receptor, Fibroblast Growth Factor, Type 1; Reflex, Startle; Schizophrenia; Sensory Gating; Thiophenes

2012